Lillian Kim is a corporate partner and member of the firm’s Public M&A/Corporate Governance and Technology and Life Sciences Groups. Ms. Kim focuses her practice on advising public companies, boards of directors and special committees, and private equity firms in connection with mergers and acquisitions, strategic investments and other significant corporate matters. She also advises clients on corporate governance and securities law disclosure and compliance. She has represented clients across a broad range of industries, including healthcare, pharmaceuticals, biotechnology, information technology, software, financial services, retail and consumer products, and real estate.

Ms. Kim serves as a member of the firm’s New York Hiring Committee, Women’s Initiative and the Committee on Racial and Ethnic Diversity.





Ms. Kim’s notable representations include:


  • Mimecast in its $5.8 billion sale to Permira
  • Slack Technologies in its $27.7 billion sale to Salesforce
  • Virtusa Corporation in its $2 billion sale to Baring Private Equity Asia
  • Help/Systems in its $217 million take-private of GlobalSCAPE
  • Monotype Imaging in its $825 million sale to HGGC
  • Imprivata in its $544 million sale to Thoma Bravo
  • Opower in its $532 million sale to Oracle
  • Planet Payment in its $257 million sale to Fintrax Group

Life Sciences

  • Trillium Therapeutics in its $2.3 billion sale to Pfizer
  • Chiasma in its sale to Amryt Pharma
  • Special Committee of NantKwest in NantKwest’s merger with ImmunityBio
  • PAREXEL International in its $5 billion sale to Pamplona Capital Management
  • Teva Pharmaceutical in its $3.2 billion acquisition of Auspex Pharmaceuticals
  • AMAG Pharmaceuticals in its $500 million sale to Covis Pharma, an Apollo Global Management company
  • Ocata Therapeutics in its $380 million sale to Astellas Pharma
  • Dimension Therapeutics in its $151 million sale to Ultragenyx Pharmaceutical
  • Juniper Pharmaceuticals in its $139 million sale to Catalent
  • Neon Therapeutics in its $97 million sale to BioNTech


  • TIER REIT in its $7.8 billion merger with Cousins Properties
  • Amplify Snack Brands in its $1.6 billion sale to The Hershey Company
Professional Experience

Prior to joining Goodwin, Ms. Kim practiced with Fried, Frank, Harris, Shriver & Jacobson LLP and Linklaters LLP.


In 2022, Ms. Kim was selected to join the Leadership Council on Legal Diversity Fellows Program.

Ms. Kim was recognized by Lawdragon as one of the 500 Leading Dealmakers in America, with particular emphasis on Technology/Life Sciences M&A and Corporate Governance (2021 and 2022).

While attending law school, Ms. Kim was a senior editor for the University of Pennsylvania Journal of Business Law.

In The News









JD, 2010
University of Pennsylvania Carey Law School
CBPP, 2010
The Wharton School at the University of Pennsylvania
BA, 2004
Wellesley College



New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique